Biocon Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 ,inter alia, to consider and approve Intimation for the Board Meeting and ....
BIOCON · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Biocon has informed the stock exchanges that its Board of Directors will meet on February 12, 2026 to approve and take on record the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025 (Q3 FY26). An earnings conference call for analysts and investors has been scheduled for February 13, 2026 at 9:00 AM IST, conducted over Zoom, with audio and video recordings to be made available afterwards on the company website. The trading window for dealing in Biocon securities is closed from January 1, 2026 to February 14, 2026 (both days inclusive) and will reopen on February 15, 2026, in line with insider trading regulations. No financial figures, guidance, or outcomes are disclosed in this filing — it is purely a procedural intimation ahead of the upcoming results announcement.
This is a routine pre-results announcement and has no direct impact on the stock. Investors should watch the February 12 board meeting outcome and the February 13 earnings call for actual Q3 numbers and management commentary, which could move the stock.